Company news
Hydrix Limited (ASX:HYD) news
Hydrix Limited news releases on 6ix. Latest, Oct 20, 2022: Completion of Retail Entitlement Offer
Press releases — page 2
Completion of Retail Entitlement Offer
October 19, 2022
Contract with Cyban Pty Ltd and Further Cleansing Notice
September 28, 2022
Completion of Institutional Component of Entitlement Offer
September 18, 2022
Investor Presentation
September 15, 2022
Entitlement Offer
September 15, 2022
FY2022 Appendix 4E and Financial Report
August 30, 2022
Hydrix receives Singapore HSA approval for Guardian device
August 14, 2022
Loyalty Options Offer and Affirmation of Key Milestones
August 7, 2022
Development partnership with Scandinavian Realheart
May 16, 2022
Hydrix : Application for quotation of securities - HYD
April 14, 2022
Hydrix : Proposed issue of securities - HYD
April 6, 2022
Hydrix : Notification regarding unquoted securities - HYD
April 3, 2022
Half Year Trading Update
February 28, 2022
Hydrix completes A$2.82M placement
February 27, 2022
Appendix 4C
January 30, 2022
Quarterly Activities Report
January 30, 2022
MEM: Reaches settlement agreement with Hydrix
August 31, 2021
FY2021 Appendix 4E and Financial Report
August 31, 2021
FY2021 Letter from Executive Chairman
August 31, 2021
Commercial arrangement between Hydrix and Memphasys
August 31, 2021
AngelMed completes its first USA commercial Guardian implant
August 1, 2021
Hydrix completes TGA submission for AngelMed Guardian System
July 20, 2021
Investor Presentation - AngelMed Guardian FDA Approval
June 30, 2021
AngelMed receives FDA approval for Guardian upgraded battery
June 27, 2021
2020 AGM - Executive Chairmans Presentation
December 11, 2020
First in human trials of Phyzhon Health PHYRARI FFR-WIRE
December 9, 2020
Phyzhon appoints Hydrix as exclusive distributor
October 29, 2020
Hydrix raises $10m under institutional placement
October 29, 2020
Trading Halt
October 27, 2020
Update on AngelMed Guardian implants in Singapore
October 21, 2020
Implantation of Next-Generation AngelMed Guardian in US
September 30, 2020
FY2020 Results Presentation
August 25, 2020
FY2020 Results Announcement
August 25, 2020
FY2020 Letter from Executive Chairman
August 25, 2020
FY2020 Appendix 4E and Financial Report
August 25, 2020
First AngelMed Guardian implants in Asia-Pacific
August 16, 2020
Hydrix : Results of Hydrix Entitlement Offer
August 5, 2020
Appendix 4C and Market Update
July 30, 2020
Results of Hydrix Entitlement Offer
July 27, 2020
Prospectus
July 6, 2020
Underwritten Entitlement Offer and Placement to raise $3M
July 5, 2020
COVID-19 Business Update and Withdrawal of FY20 Guidance
April 9, 2020
2019 AGM Chairman and CEO Presentation
December 12, 2019
Hydrix Trading Update
December 11, 2019
Execution of Pure Asset Management Facility Agreement
November 15, 2019
Hydrix successfully raises $2.5M
November 3, 2019
Appendix 4C and Quarterly Update
October 15, 2019
Exclusive APAC distributorship of implantable cardiac device
October 2, 2019
Hydrix Secures A$5.0M Finance Facility
September 16, 2019
FY19 Results Announcement
August 30, 2019